Related Experiment Video
Updated: Aug 23, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Blood pressure and renal function after kidney donation from hypertensive living donors
Stephen C Textor1, Sandra J Taler, Nancy Driscoll
1Department of Medicine, Divisions of Nephrology and Hypertension, W9A, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. textor.stephen@mayo.edu
Insights
Selected hypertensive patients with normal kidney function can safely donate kidneys. This study found no adverse effects on blood pressure, kidney function, or urine protein in hypertensive donors one year post-donation.
Area of Science:
- Nephrology
- Transplant Surgery
- Hypertension Management
Background:
- Increasing end-stage kidney disease necessitates expanding the living kidney donor pool.
- Essential hypertension is a common comorbidity, previously limiting donor eligibility.
- This study investigated the safety of accepting donors with controlled hypertension.
Purpose of the Study:
- To evaluate the outcomes of living kidney donors with essential hypertension.
- To assess blood pressure, kidney function, and urinary protein excretion one year post-nephrectomy.
- To determine the safety of including selected hypertensive individuals in living kidney donation programs.
Main Methods:
- Prospective study of 148 living kidney donors, including 24 with pre-existing hypertension.
- Detailed measurements of blood pressure (clinic, nurse, and ambulatory), glomerular filtration rate (GFR), and urine protein.
- Assessment of renal and clinical characteristics before and 6-12 months after nephrectomy.
Main Results:
- Hypertensive donors experienced a significant reduction in blood pressure post-donation with treatment.
- Hypertensive donors were older and had a slightly lower GFR post-donation compared to normotensive donors.
- No significant changes in urine protein or microalbumin were observed in either group.
Conclusions:
- White individuals with moderate essential hypertension and normal kidney function show no adverse outcomes one year after kidney donation.
- Selected hypertensive donors demonstrate acceptable safety profiles regarding blood pressure, GFR, and urinary protein.
- Further long-term studies are warranted, but current data support considering selected hypertensive patients for living kidney donation.
Background:
Rising numbers of patients reaching end-stage kidney disease intensify the demand for expansion of the living-kidney-donor pool. On the basis of low risk in white donors with essential hypertension, our transplant center undertook a structured program of accepting hypertensive donors if kidney function and urine protein were normal. This study reports outcomes of hypertensive donors 1 year after kidney donation.
Methods:
We studied detailed measurements of blood pressure (oscillometric, hypertensive therapy nurse [RN], and ambulatory blood pressure monitoring [ABPM]), clinical, and renal characteristics (iothalamate glomerular filtration rate [GFR], urine protein, and microalbumin) in 148 living kidney donors before and 6 to 12 months after nephrectomy. Twenty-four were hypertensive (awake ABPM>135/85 mm Hg and clinic/RN BP>140/90 mm Hg) before donation.
Results:
After 282 days, normotensive donors had no change in awake ABPM pressure (pre 121 +/- 1/75 +/- 2 vs. post 120 +/- 1/ 5 +/- 1 mm Hg), whereas BP in hypertensive donors fell with both nonpharmacologic and drug therapy (pre 142 +/- 3/85 +/- 2 to post 132 +/- 2/80 +/- 1 mm Hg, P<.01). Hypertensive donors were older (53.4 vs. 41.4 years, P<.001) and had lower GFR after kidney donation (61 +/- 2 vs. 68 +/- 1 mL/min/1.73m, P<.01). After correction for age, no independent BP effect was evident for predicting GFR either before or after nephrectomy. Urine protein and microalbumin did not change in either group after donor nephrectomy.
Conclusions:
Our results indicate that white subjects with moderate, essential hypertension and normal kidney function have no adverse effects regarding blood pressure, GFR, or urinary protein excretion during the first year after living kidney donation. Although further studies are essential to confirm long-term safety, these data suggest that selected hypertensive patients may be accepted for living kidney donation.
Related Concept Videos
Kidney Transplant I: Introduction
Hypertension and Regulation of Blood Pressure
Kidney Transplant II: Surgical Procedure
Kidney Structure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Kidney Transplant III: Nursing Management

